alt

Rakisheva Amina

Rakisheva Amina

PROFESSIONAL POSITIONS 2017- 2022 Consultant in Cardiology Department in Scientific Research Institute of Cardiology and Internal Diseases 2023- now Head of the Heart Failure Department POSITIONS IN PROFESSIONAL ORGANIZATIONS Since 2012 Member of Association of Cardiologists of Kazakhstan 2013-2016 ESC National guidelines coordinator from Kazakhstan Current positions: 2022- Now Board Member, Kazakh Heart Failure Society 2016-2022 Chairman, Working group on Heart Failure of the Association of Cardiologists of Kazakhstan. 2018-2020 Member, ESC Cardiologists of Tomorrow Nucleus 2018- Now Editorial Board Member of JACC: Case Reports 07.2020-Now Board Member of the Heart Failure Association (2022-2024 Mandate) 09.2020-2020 ESC Board Committee for Young Cardiovascular Professionals (2020-2022 Mandate) 09.2020- Now Member of the ESC Committee for Practice Guidelines (2022-2024 Mandate) 2021- Now Editorial Board Member of Cardiac Failure Review

Currículum Vitae

Proficient in handling fast-paced emergency scenarios and skilled in crisis resolution. Demonstrates efficiency in time management, task prioritization, and making critical decisions to enhance patient care standards. Recognized for swiftly identifying needs, resolving issues, and fostering rapport with a wide array of patients and their families, all while maintaining a calm, diplomatic, and supportive demeanor. Highly reliable and consistently seeks avenues to take initiative and demonstrate accountability.


EDUCATION

 
Medical School 1999-2005
 
Kazakh National Medical University named by S.D.Asfendiyarov in Almaty, graduated with honors.
 

 
2005-2006
Internship
 
Kazakh National Medical University named by S.D.Asfendiyarov, graduated with honors.
 

 
2011-2014
Residency
 
Scientific Research Institute of Cardiology and Internal Diseases, graduated with honors.
 
2014-2018
PhD

 

EDUCATION ABROAD
 
Kazakh National Medical University named by S.D. Asfendiyarov, Almaty, Kazakhstan.
The thesis: Prognostic implication of iron deficiency anemia in Heart Failure patients”.
 

August-December 2007    Training in cardiology in Kaunas Medical University, Lithuania


 
February-May 2012
 
Training in cardiology in Cardiology department in Nagasaki Medical Centre, Omura, Nagasaki prefecture, Japan
 

 

January 2016- October 2017    Postgraduate Course on Heart Failure in Zurich


June 2017    Clinical Trialists Summer School Heart Failure

 
January 2020-
July 2020
 
EACVI grant winner “Cardiac Imaging in the Interventional Management of Mitral and Tricuspid Regurgitation” at Department of Cardiology
University Hospital Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg
 


12.12.2020    Training certificate on GCP for investigators_RDD-TRN-REG-1-4.0-EN

EXPERIENCE

City Cardiology Center, Almaty

 
November    2023-
present time
 
Deputy Director
 

Lead efforts to enhance patient care quality, implementing protocols and procedures to ensure the highest standards of care are maintained across all departments.
Foster collaboration between medical staff, nursing teams, and other healthcare professionals to streamline processes, improve communication, and enhance patient outcomes.
Implement training and development programs to continuously enhance the skills and knowledge of medical and nursing staff, ensuring they stay abreast of the latest medical advancements and best practices.
 
Ensure compliance with all regulatory requirements and accreditation standards, proactively addressing any issues or concerns to maintain the facility's reputation for excellence and patient safety.
Promote a culture of research and innovation within the facility, supporting initiatives to advance medical knowledge, develop new treatments, and improve patient care outcomes.


SCIENTIFIC RESEARCH INSTITUTE FOR CARDIOLOGY AND INTERNAL DISEASE
June 2016- September
2023    Head of the Cardiology department

Oversee a unit comprising 40 beds, along with a team of 3 doctors and 12 nurses.
Responsible for coordinating and supervising all aspects of patient care within the department;
Ensure high standards of quality and efficiency.
Provided guidance and support to my team, fostering a collaborative and cohesive working environment aimed at delivering optimal healthcare outcomes for our patients

 
August    2006-June 2016
 
Ward Cardiologist
 
Evaluate patients with cardiovascular symptoms, conduct physical examinations, review medical history, and order diagnostic tests such as ECGs, echocardiograms, stress tests, and cardiac catheterizations to diagnose and determine the severity of heart conditions.
Develop treatment plans tailored to each patient's condition. This may include medications, lifestyle modifications, and procedures such as angioplasty, stent placement, or pacemaker implantation.
Educate patients and their families about their heart condition, treatment options, and strategies for managing their health post-discharge.
Work closely with other members of the healthcare team, including nurses, nurse practitioners, physician assistants, and allied health professionals, to ensure coordinated and comprehensive care.


POSITIONS IN PROFESSIONAL ORGANIZATIONS

Since 2012    Member of Association of Cardiologists of Kazakhstan
2013-2016    ESC National guidelines coordinator from Kazakhstan Current positions:
2022- Now    Board Member, Kazakh Heart Failure Society
 
2016-2022    Chairman, Working group on Heart Failure of the Association of
Cardiologists of Kazakhstan.

2018-2020    Member, ESC Cardiologists of Tomorrow Nucleus

2018- Now    Editorial Board Member of JACC: Case Reports

07.2020-Now    Board Member of the Heart Failure Association (2022-2024
Mandate)

09.2020-2020    ESC Board Committee for Young Cardiovascular Professionals
(2020-2022 Mandate)

09.2020- Now    Member of the ESC Committee for Practice Guidelines (2022-
2024 Mandate)

2021- Now    Editorial Board Member of Cardiac Failure Review

Presentations:
1.    Annual Congress of Cardiology of Argentina (October, 2018):
“Insuficiencia mitral I: Tratamiento insuficiencia mitral functional”.

2.    ESC Congress 2018: “An elderly patient with atrial fibrillation”.

3.    Heart Failure 2019: “Epidemiology of atrial fibrillation among heart failure patients according to ejection fraction”.

4.    Annual Congress of the TSC (December 2020, Turkey): “TSC Wrap-up 2020 in Cardiology. SGLT inhibitors: The Fourth Cornerstone of the HF Treatment”.

5.    Symposium of Russian Society of Cardiology (December 2020, Russia): “Hyperkalemia in Heart Failure Patients”.

6.    Heart Failure 2021: “Sex-based differences in HFpEF: implications for the diagnostic algorithm”.
7.    Annual Congress of the Russian Society on Heart Failure 2021: “Congestion in heart failure: optimal treatment “.

8.    Heart Failure 2023: “Quality of life across the HF phenotypes”.

9.    Heart Failure 2023: “Heart failure management in pregnancy”.

Chairperson:
1.    ESC Congress 2018: “ICD and CRT therapy in heart failure

2.    Heart Failure 2019: “Lifestyle interventions in chronic heart failure”.
 
3.    ESC Congress 2019: “Amyloidosis: more complex than we thought?”

4.    ESC Congress 2019: “Expert Advice - Heart failure management in women, the elderly and cancer patients”.
5.    Heart Failure 2021: Current pharmacological treatment of heart failure with mid-range ejection fraction.
6.    Heart Failure 2021: “How to optimise treatment according to patient profile in HFrEF”.
7.    Heart Failure Association Webinar 2021: “How to optimise RAASi therapy in patients with hyperkalaemia”.
8.    Heart Failure Association Webinar 2022: “Improving Quality of life”.

9.    Heart Failure Association Webinar 2023: “Gender difference in HF”.

 

Publications:

1.    Y. Lopatin, M.R. Cowie, A. Grebennikova, H. S. Sisakian, Z. M. Pagava, H. G. Hayrapetyan, T.
A. Abdullaev, L. G. Voronkov, A. I. Chesnikova, V. I. Tseluyko, E. I. Tarlovskaya, G.M. Dadashova, S. F. Berkinbaev, M. G. Glezer, N.A. Koziolova, A. G. Rakisheva, Z. V. Kipiani, A.
K. Kurlyanskaya. Optimization of heart rate lowering therapy in hospitalized patients with heart failure: Insights from the Optimize Heart Failure Care Program. International Journal of Cardiology 260 (2018) 113–117.
2.    A. Rakisheva, M. Marketou, A. Klimenko, T. Troyanova-Shchutskaia, P. Vardas. Hyperkalemia in heart failure: Foe or friend? Clin Cardiol. 2020;1–10.
3.    A. Rakisheva, M. Marwan, S.Achenbach. The ISCHEMIA trial: Implications for non-invasive imaging. Anatolian Journal of Cardiology 24 (1), 2.
4.    R. Ladeiras-Lopes, L. Baciu, J. Grapsa, A. Sohaib, R. Vidal-Perez, A. Bohm, H. Silvola, M. Rubini Gimenez, S. Muscoli, M. Wallner, A. Rakisheva, V. Klaudia Nagy, M. R Cowie, S. C Clarke, S. Achenbach. Social media in cardiovascular medicine: a contemporary review. European Heart Journal-Digital Health 1 (1), 10-19.
5.    A. Rakisheva, O. Mashkunova, A. Kolesnikov, S. Urazalina, A. Mussagaliyeva. A Rare Case of Takayasu Arteritis With Total Left Main Coronary Artery Occlusion. J Am Coll Cardiol Case Rep. 2020 Feb, 2 (2) 312–313.
6.    Rosano, G., Jankowska, E.A., Ray, R., Metra, M., Abdelhamid, M., Adamopoulos, S., Anker, S.D., Bayes-Genis, A., Belenkov, Y., Gal, T.B., Böhm, M., Chioncel, O., Cohen-Solal, A., Farmakis, D., Filippatos, G., González, A., Gustafsson, F., Hill, L., Jaarsma, T., Jouhra, F., Lainscak, M., Lambrinou, E., Lopatin, Y., Lund, L.H., Milicic, D., Moura, B., Mullens, W., Piepoli, M.F., Ponikowski, P., Rakisheva, A., Ristic, A., Savarese, G., Seferovic, P., Senni, M., Thum, T., Tocchetti, C.G., Van Linthout, S., Volterrani, M. and Coats, A.J. (2021), COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail, 23: 1806-1818. https://doi.org/10.1002/ejhf.2356
 
7.    Mullens W, Coats A, Seferovic P, Metra M, Mebazaa A, Ruschitzka F, Filippatos G, Volterrani M, Ponikowski P, Jankowska EA, Chioncel O, McDonagh TA, Piepoli MF, Milicic D, Thum T, Hill L, Abdelhamid M, Adamopoulos S, Belenkov Y, Gal TB, Böhm M, Cohen- Solal A, Gustafsson F, Jaarsma T, Moura B, Rakisheva A, Ristic A, Bayes-Genis A, Van Linthout S, Anker SD, Tocchetti CG, Lopatin Y, Lund L, Savarese G, Čelutkienė J, Cowie M, Lambrinou E, Ray R, Lainscak M, Skouri H, Wallner M, Rosano GMC. Education and Certification on Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2022 Jan 11. doi: 10.1002/ejhf.2430. Epub ahead of print. PMID: 35014132.
8.    González, A., Richards, A.M., de Boer, R.A., Thum, T., Arfsten, H., Hülsmann, M., Falcao- Pires, I., Díez, J., Foo, R.S., Chan, M.Y., Aimo, A., Anene-Nzelu, C.G., Abdelhamid, M., Adamopoulos, S., Anker, S.D., Belenkov, Y., Ben Gal, T., Cohen-Solal, A., Böhm, M., Chioncel, O., Delgado, V., Emdin, M., Jankowska, E.A., Gustafsson, F., Hill, L., Jaarsma, T., Januzzi, J.L., Jhund, P.S., Lopatin, Y., Lund, L.H., Metra, M., Milicic, D., Moura, B., Mueller, C., Mullens, W., Núñez, J., Piepoli, M.F., Rakisheva, A., Ristić, A.D., Rossignol, P., Savarese, G., Tocchetti, C.G., Van Linthout, S., Volterrani, M., Seferovic, P., Rosano, G., Coats, A.J. and Bayés-Genís, A. (2022), Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail, 24: 927-
943. https://doi.org/10.1002/ejhf.2493.
9.    Aimo, A., Vergaro, G., González, A., Barison, A., Lupón, J., Delgado, V., Richards, A.M., de Boer, R.A., Thum, T., Arfsten, H., Hülsmann, M., Falcao-Pires, I., Díez, J., Foo, R.S., Chan, M.Y.Y., Anene-Nzelu, C.G., Abdelhamid, M., Adamopoulos, S., Anker, S.D., Belenkov, Y., Ben Gal, T., Cohen-Solal, A., Böhm, M., Chioncel, O., Jankowska, E.A., Gustafsson, F., Hill, L., Jaarsma, T., Januzzi, J.L., Jhund, P., Lopatin, Y., Lund, L.H., Metra, M., Milicic, D., Moura, B., Mueller, C., Mullens, W., Núñez, J., Piepoli, M.F., Rakisheva, A., Ristić, A.D., Rossignol, P., Savarese, G., Tocchetti, C.G., van Linthout, S., Volterrani, M., Seferovic, P., Rosano, G., Coats, A.J., Emdin, M. and Bayes-Genis, A. (2022), Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail, 24: 944- 958. https://doi.org/10.1002/ejhf.2522.
10.    Abdelhamid, M., Rosano, G., Metra, M., Adamopoulos, S., Böhm, M., Chioncel, O., Filippatos, G., Jankowska, E.A., Lopatin, Y., Lund, L., Milicic, D., Moura, B., Ben Gal, T., Ristic, A., Rakisheva, A., Savarese, G., Mullens, W., Piepoli, M., Bayes-Genis, A., Thum, T., Anker, S.D., Seferovic, P. and Coats, A.J. (2022), Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?. Eur J Heart Fail. https://doi.org/10.1002/ejhf.2594.
11.    Marco Metra, Daniela Tomasoni, Marianna Adamo, Antoni Bayes-Genis, Gerasimos Filippatos, Magdy Abdelhamid, Stamatis Adamopoulos, Stefan D Anker, Laura Antohi, Michael Böhm, Frieder Braunschweig, Tuvia Ben Gal, Javed Butler, John GF Cleland, Alain Cohen-Solal, Kevin Damman, Finn Gustafsson, Loreena Hill, Ewa Jankowska, Mitja Lainscak, Lars H Lund, Theresa McDonagh, Alexandre Mebazaa, Brenda Moura, Wilfried Mullens, Massimo Piepoli, Piotr Ponikowski, Amina Rakisheva, Arsen Ristic, Gianluigi Savarese, Petar Seferovic, Rajan Sharma, Carlo Gabriele Tocchetti, Mehmet Birhan Yılmaz, Cristiana Vitale, Maurizio Volterrani, Stephan Von Haehling, Ovidiu Chioncel, Andrew JS Coats, Giuseppe Rosano. Worsening of chronic heart failure: definition, epidemiology, management and
 
prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology. https://doi.org/10.1002/ejhf.2874
12.    Docherty KF, Lam CSP, Rakisheva A, Coats AJS, Greenhalgh T, Metra M, Petrie MC, Rosano GMC. Heart failure diagnosis in the general community - Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2023 Aug;25(8):1185-1198. doi: 10.1002/ejhf.2946. Epub 2023 Jul 17. PMID: 37368511.
13.    Sambola A, Halvorsen S, Adlam D, Hassager C, Price S, Rosano G, Schiele F, Holmvang L, de Riva M, Rakisheva A, Sulzgruber P, Swahn E. Management of cardiac emergencies in women: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the Heart Failure Association (HFA), and the European Heart Rhythm Association (EHRA) of the ESC, and the ESC Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Open. 2024 Feb 26;4(2):oeae011. doi: 10.1093/ehjopen/oeae011. PMID: 38628674; PMCID: PMC11020263.
14.    Rakisheva A, Sliwa K, Bauersachs J, Van Linthout S, Chopra VK, Bayes-Genis A, Fruzzetti F, Cannatà A, Deniau B, Mebazaa A, Savarese G, Ray R, Vitale C, Metra M, Rosano GMC. Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC. Eur J Heart Fail. 2024 Apr 28. doi: 10.1002/ejhf.3246. Epub ahead of print. PMID: 38679896.
15.    Nurzhanova M, Musagaliyeva A, Zhakypova R, Senkibayeva D, Rakisheva A. Use of sacubitril/valsartan early after CABG. Open Heart. 2024 Jan 18;11(1):e002492. doi: 10.1136/openhrt-2023-002492. PMID: 38238027; PMCID: PMC10806467.
16.    López-Fernández T, Farmakis D, Ameri P, Asteggiano R, de Azambuja E, Aznar M, Barac A, Bayes-Genis A, Bax JJ, Bergler-Klein J, Boriani G, Celutkiene J, Coats A, Cohen-Solal A, Córdoba R, Cosyns B, Filippatos G, Fox K, Gulati G, Inciardi RM, Lee G, Mamas MA, Novo G, Plummer C, Psyrri A, Rakisheva A, Suter T, Tini G, Tocchetti CG, Toutouzas K, Wilhelm M, Metra M, Lyon AR, Rosano GMC. European Society of Cardiology Core Curriculum for cardio-oncology. Eur J Heart Fail. 2023 Dec 7. doi: 10.1002/ejhf.3102. Epub ahead of print. PMID: 38059343.